Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

The vaccine is indicated for use in infants and children 6 weeks through 5 years of age (before the 6^th birthday).
Immune responses in recipients could be elicited by immunization of PCV13-TT, and this vaccine is indicated for the prevention of invasive diseases caused by 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) of Streptococcus pneumoniae.
The vaccine does not protect against diseases caused by Streptococcus pneumoniae serotypes that are not contained in the vaccine.

Pneumocon 13 Indications/Uses

vaccine, pneumococcal

Manufacturer:

Yuxi Walvax Biotechnology

Distributor:

2 World Traders